Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Other Working Capital Changes (2023 - 2025)

Immunome (IMNM) has disclosed Other Working Capital Changes for 3 consecutive years, with $237184.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Working Capital Changes rose 103.8% year-over-year to $237184.0, compared with a TTM value of $237184.0 through Sep 2025, up 111.3%, and an annual FY2025 reading of -$166000.0, down 142.51% over the prior year.
  • Other Working Capital Changes was $237184.0 for Q3 2025 at Immunome, down from $8.2 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $27.6 million in Q1 2023 and bottomed at -$27.7 million in Q2 2023.
  • Average Other Working Capital Changes over 3 years is $63350.4, with a median of -$25000.0 recorded in 2024.
  • Peak annual rise in Other Working Capital Changes hit 19692.86% in 2025, while the deepest fall reached 11604.0% in 2025.
  • Year by year, Other Working Capital Changes stood at $4.2 million in 2023, then plummeted by 165.13% to -$2.7 million in 2024, then skyrocketed by 108.66% to $237184.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for IMNM at $237184.0 in Q3 2025, $8.2 million in Q2 2025, and -$2.9 million in Q1 2025.